The MarketWatch News Department was not involved in the creation of this content. -- Accelerating AI-enabled acute-care diagnostics by years and millions of dollars -- HAIFA, Israel, Jan. 12, 2026 ...

– Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management – – MeMed and Physicians Premier Celebrated Milestone Event in Corpus Christi, Texas – ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. MeMed Ltd. announced that it has received a government ...

ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed, a leader in host-response diagnostics, today announced the addition of three distinguished experts to its advisory board to accelerate its ...

While most infectious disease tests search a sample for the presence of a particular pathogen, MeMed’s diagnostic collects evidence from the immune system itself and helps identify the culprit by ...

— Real-world data and KOL insights highlight MeMed BV’s supportive role in emergency medicine — MeMed, a leader in host-response diagnostics, announced today that several oral presentations at the ...

-MeMed BV Flex™ simultaneously measures multiple host proteins, paired with machine learning, to deliver highly accurate results in 15 minutes from just a few drops of blood- -Designed for use in ...

Israeli diagnostics company MeMed was just awarded $9.2 million from the U.S. Defense Threat Reduction Agency (DTRA) to develop a faster instrument to differentiate between bacterial and viral ...

MeMed has raised over $70 million to support its point-of-care immune system diagnostic for distinguishing between bacterial and viral infections. The company aims to cut down on the misuse of ...

Acute and emergency care remain one of the most consequential blind spots in modern medicine, where clinicians must make high-stakes decisions within hours, often without real-time biological insight.

HAIFA, Israel, Jan. 12, 2026 /PRNewswire/ -- MeMed, the leader in host-response diagnostics, announced it has been awarded a competitive national grant through the IIA to establish an acute-care ...